NGOs Detail Changes For Public Health In RCEP Asian Trade Pact 31/03/2017 by Catherine Saez, Intellectual Property Watch 1 Comment Concerns continue to grow among civil society about provisions in a major trade agreement in the Asian region. Of specific worry is the intellectual property chapter containing in particular a data exclusivity clause, and the linkage between the investment chapter and the IP chapter.
UK Professor Charts Path To Reconciling IP Rights, Farmers’ Rights 27/03/2017 by Catherine Saez, Intellectual Property Watch 1 Comment The role of farmers in agricultural innovation can be perceived in different ways. Proponents of intellectual property rights view farmers mainly as recipients of innovation, while others view farmers as main drivers of innovation. Considering those seemingly contradictory points of views, some measures could help reconcile IP rights and farmers’ rights, a UK professor in international governance has said.
Mining Is The New Reading 23/03/2017 by Monika Ermert for Intellectual Property Watch 1 Comment Representatives of the research and academic community applauded amendments by the rapporteur to the draft new European Union Copyright Directive in yet another hearing on the megaproject yesterday in Brussels. Especially welcomed was the rapporteur’s proposal to extend the scope of an exemption for text and data mining. Representatives of publishers, on the other hand, said there is no evidence of the need for additional mandatory exemptions.
Marrakesh Treaty For Blind Readers Jeopardised By EU Publishing Industry Lobbying, Group Says 21/03/2017 by Catherine Saez, Intellectual Property Watch 4 Comments The treaty adopted almost four years ago in Marrakesh allowing for exceptions to copyright for the benefit of visually impaired people was hailed as a victory for human rights over private rights. However, as the European Union is preparing to ratify the treaty, according to a civil society group report, intense lobbying by the publishing industry is influencing the debate and might diminish the hard-gained ground in the treaty on copyright exceptions. The World Blind Union, meanwhile, said it finds the report “revealing and shocking”.
A Look At Optimal Patent Regimes For Canada 21/03/2017 by Intellectual Property Watch 2 Comments A new policy brief from the Centre for International Governance Innovation, in Waterloo, Canada argues that Canada should pursue a weaker national patent regime. Acknowledging that Canada already has agreed to certain levels of protection through international treaties and trade agreements, Blit warns that future agreements that strengthen intellectual property protections would not benefit Canada.
Do US Patent Incentives Need To Change To Get The ‘Cancer Moonshot’ Off The Ground? 16/03/2017 by Kim Treanor for Intellectual Property Watch 1 Comment In December, the United States Congress passed a bill with a monumental goal: engaging the private sector to work with each other, and with the government, to develop new treatments for cancer. The mechanics of cancer research, however, may require fundamental changes to our patent system if the initiative is to be successful. Intellectual Property Watch recently sat down with Jacob Sherkow, associate professor of law and affiliated faculty at the Innovation Center for Law and Technology at New York University Law School, to discuss challenges to overcome to get the Moonshot off the ground.
3D Printing In Africa: Huge Benefit Or Big IP Threat? 13/03/2017 by Munyaradzi Makoni for Intellectual Property Watch Leave a Comment CAPE TOWN, South Africa – The five-metre tall 3D printer dwarfs four engineers in the renewable energy laboratory at the Nelson Mandela Metropolitan University, the biggest tertiary institution in the Eastern Cape, South Africa.
UN High-Level Panel On Access To Medicines Takes Next Step At Human Rights Council 09/03/2017 by Catherine Saez, Intellectual Property Watch 2 Comments The United Nations Human Rights Council held a panel discussion yesterday to exchange views on good practices and key challenges relevant to access to medicines. The panel gave a large part of the discussion to the recent report of the United Nations Secretary General’s High-Level Panel on Access to Medicines, much to the chagrin of the European Union and the United States.
Workshop: How To Tackle The High Cost Of Prescription Drugs In The US 09/03/2017 by Kim Treanor for Intellectual Property Watch 1 Comment A recent workshop held on the doorstep of policymakers in the United States drew speakers from academic and activist circles to examine the mechanisms in US law which could help lead to lower prescription drug prices.
Paint Medical Patents Green Or Improve Efficacy 08/03/2017 by Intellectual Property Watch 1 Comment Danny Friedmann writes: When the holder of a medical patent finds herself on the patent cliff, staring into the abyss of a patentless and incomeless future, she will become very ingenious in applying for new uses, new pathways of delivery and new doses of the known substance. Painting a new layer of green over the patent that must give the impression of a new invention. It is the duty of the legislator to limit this kind of behavior if it stifles access to generic medicines. How can the interests of patent holders and patients be reconciled?